Sinopharm Capital is a private equity firm in China that focuses on medical and healthcare, pharmaceuticals, biotechnology, medical devices, healthcare and medical supply, and services for elderly and persons with disability. Founded 2012 in Shanghai, China, it invests in early stage companies. Its portfolio companies include ArteryFlow, Baicare, Synyi, Novena Global Healthcare Group, Suzhou and Science Technology Development, Dingdang Kuaiyao, HealthCare Biotech, Skynor Medical, Virogin Biotech, and GenFleet Therapeutics. As of February 2020, Sinopharm Capital has made 18 investments. Their most recent investment was on December 31, 2019 with ArteryFlow. Sinopharm Capital has raised a single venture fund, Sino-Singapore Healthcare Fund. This fund was announced on June 21, 2019 and raised a total of $150M.
Timeline
Funded Companies
People
Xiaoming Yang
Managing Director
Aimin Wu
President
Fei Jiang
Executive Vice-President
Yong Kuang
Managing Director
Yunlei Gong
Vice-President
Further reading
Documentaries, videos and podcasts
Companies
ArteryFlow
Baicare
Dingdang Kuaiyao
GenFleet Therapeutics
HealthCare Biotech
Novena Global Healthcare Group
Skynor Medical
Suzhou And Science Technology Development
Synyi
Virogin Biotech
References
Company attributes
Venture Capital Firm attributes
Categories
Related Topics
Contributors
- 1
Marie Gabrielle Laguna- Bedia
Co-founder and Managing Partner of Eternus Global. Physician of internal medicine, app developer and entrepreneur - 2
Edita Rexha
Economist - 3
Melanie Manipula
Helping organize knowledge. - 4
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 5
Julius John Villarisco
Every day is a new learning for me, new opportunity every time. Never limit my self, think outside the box. - 6
Henry Ogolla
Passionate about reading and writing. - 7
Aime Anne Nisay
QA Engineer of web and mobile applications